share_log

Soleno Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Carlyle Group Inc.(6.2%),Carlyle Holdings I GP Inc.(6.2%), etc.

Soleno Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-The Carlyle Group Inc.(6.2%),Carlyle Holdings I GP Inc.(6.2%)等

美股SEC公告 ·  10/15 16:36
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息